BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28017733)

  • 1. Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.
    Miller HK; Braun TM; Stillwell T; Harris AC; Choi S; Connelly J; Couriel D; Goldstein S; Kitko CL; Magenau J; Pawarode A; Reddy P; Riwes M; Yanik GA; Levine JE
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):522-528. PubMed ID: 28017733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
    Yu J; Lal L; Anderson A; DuCharme M; Parasuraman S; Weisdorf D
    Support Care Cancer; 2020 Nov; 28(11):5491-5499. PubMed ID: 32172407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplant β2-Microglobulin Is Associated with the Risk of Acute Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant.
    Costa-Lima C; Miranda ECM; Colella MP; Aranha FJP; de Souza CA; Vigorito AC; De Paula EV
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1329-1332. PubMed ID: 27044906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of cognitive changes in identifying those with acute graft vs. host disease following allogeneic hematopoietic cell transplant.
    Stratton J; Sylvia A; Hoodin F; Choi SW; Pawarode A; Giordani B; Votruba K
    Clin Neuropsychol; 2020 Jul; 34(5):969-980. PubMed ID: 31619131
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
    Rezvani AR; Storer BE; Storb RF; Mielcarek M; Maloney DG; Sandmaier BM; Martin PJ; McDonald GB
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1594-601. PubMed ID: 21806949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes and Healthcare Resource Utilization for Gastrointestinal Acute Graft-versus-Host Disease after Allogeneic Transplantation for Hematologic Malignancy: A Retrospective US Administrative Claims Database Analysis.
    Johnson BH; Taylor A; Kim G; Drahos J; Yang J; Akbari M; Shah NN
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):834-841. PubMed ID: 30625389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation.
    Young JH; El Jurdi N; Rayes A; MacMillan ML; Holtan SG; Cao Q; Witte J; Arora M; Weisdorf DJ
    Transplant Cell Ther; 2022 Aug; 28(8):509.e1-509.e11. PubMed ID: 35577324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?
    Tekgündüz E; Kaya AH; Bozdağ SC; Koçubaba Ş; Kayıkçı Ö; Namdaroğlu S; Uğur B; Akpınar S; Batgi H; Bekdemir F; Altuntaş F
    Transfus Apher Sci; 2016 Feb; 54(1):30-4. PubMed ID: 26922995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease.
    Vaughn JE; Gooley T; Maziarz RT; Pulsipher MA; Bhatia S; Maloney DG; Sandmaier BM; Flowers ME; Storb R; Sorror ML
    Br J Haematol; 2015 Nov; 171(3):411-6. PubMed ID: 26194447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation.
    Sadowska-Klasa A; Piekarska A; Prejzner W; Bieniaszewska M; Hellmann A
    Ann Hematol; 2018 Mar; 97(3):509-517. PubMed ID: 29255911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease.
    Matsumura-Kimoto Y; Inamoto Y; Tajima K; Kawajiri A; Tanaka T; Hirakawa T; Ino K; Asao Y; Tamogami H; Kono C; Takeda W; Okinaka K; Fuji S; Kurosawa S; Kim SW; Tanosaki R; Yamashita T; Fukuda T
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1102-1107. PubMed ID: 26968790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
    Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E; Bleesing JJ; Sullivan KE; Heimall J; Burroughs LM; Skoda-Smith S; Chandrakasan S; Yu LC; Oshrine BR; Cuvelier GDE; Thakar MS; Chen K; Teira P; Shenoy S; Phelan R; Forbes LR; Chellapandian D; Dávila Saldaña BJ; Shah AJ; Weinacht KG; Joshi A; Boulad F; Quigg TC; Dvorak CC; Grossman D; Torgerson T; Graham P; Prasad V; Knutsen A; Chong H; Miller H; de la Morena MT; DeSantes K; Cowan MJ; Notarangelo LD; Kohn DB; Stenger E; Pai SY; Routes JM; Puck JM; Kapoor N; Pulsipher MA; Malech HL; Parikh S; Kang EM;
    J Clin Immunol; 2019 Oct; 39(7):653-667. PubMed ID: 31376032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
    Front Immunol; 2018; 9():109. PubMed ID: 29456530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors.
    Sy A; Chanson D; Berano Teh J; Wong FL; Nakamura R; Dadwal S; Armenian SH
    Cancer Med; 2021 May; 10(9):2956-2966. PubMed ID: 33835722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.